Question 1

What is Replimune Group?

Accepted Answer

Replimune Group is a Company.

Question 2

How often does Replimune Group appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 157 articles.

Question 3

When was Replimune Group first tracked by Ergen?

Accepted Answer

First tracked on Jul 25, 2025.

Question 4

When was Replimune Group last mentioned in news?

Accepted Answer

Last active on Jun 26, 2026.

Question 5

What is Replimune Group's current news sentiment?

Accepted Answer

Aggregate sentiment score: -18 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Replimune Group in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Replimune Group?

Accepted Answer

Replimune Group Class Action Lawsuits (Jul 25, 2025, 26 articles).

Question 8

Who is Replimune Group most connected to?

Accepted Answer

Top relationships: United States — Food and Drug Administration, United States — Food and Drug Administration.

Question 9

How did the "Replimune Group Class Action Lawsuits" event impact Replimune Group?

Accepted Answer

Replimune Group is the target of multiple class action lawsuits due to alleged false statements regarding its IGNYTE trial, which led to the United States — Food and Drug Administration deeming the trial inadequate.

Question 10

How did the "FDA Accepts Replimune RP1 BLA Resubmission" event impact Replimune Group?

Accepted Answer

The FDA's acceptance of the BLA resubmission for RP1 is a significant step towards potential accelerated approval, which could lead to increased revenue and market presence for Replimune Group. However, the stock price was down in pre-market trading, indicating some investor caution.

Question 11

How did the "Marty Makary Resigns FDA Commissioner" event impact Replimune Group?

Accepted Answer

Replimune Group>>> experienced rejection of its melanoma therapy by the United States — Food and Drug Administration>>> under Marty Makary>>>'s leadership, leading to public criticism and contributing to the pressure for his ouster.

Question 12

How did the "Evotec Nominates Dieter Weinand Chairman" event impact Replimune Group?

Accepted Answer

Dieter Weinand currently serves on the board of Replimune Group, and will reduce his board seats to focus on his role at Evotec.

Question 13

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.